G2B Pharma’s research is focused on the development of a needle-free alternative for epinephrine using the nasal delivery route. G2B is partnering in this effort with Shin Nippon Biological Laboratories of Japan, a leading developer of nasal spray devices and delivery systems.
Our primary product candidate, G2B011, is a nasal spray formulation of epinephrine for the treatment of anaphylaxis. Anaphylaxis is a severe and life-threatening allergic reaction that affects tens of millions of people worldwide. Common causes of anaphylactic reactions include food allergies and bee stings. Epinephrine is the gold standard for treatment of anaphylaxis and is currently provided for self-administration by injection. The company believes that nasal administration offers an effective and more patient-friendly delivery route for this life-saving medication.
Company Details
- Phone
- 415-515-7614
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- g2bpharma.com
G2b Pharma Inc Questions
G2B Pharma Inc's helpline number is 415-515-7614
G2B Pharma Inc's website is g2bpharma.com
G2B Pharma Inc's LinkedIn profile is https://www.linkedin.com/company/g2b-pharma-inc
G2B Pharma Inc's industry is
Pharmaceutical Manufacturing
G2B Pharma Inc's top competitors are
G2b Biosolutions Aps,
G2b,
Highball,
4ward Solutions Inc,
G2b Solar,
Morton Enclosures,
G2b Real Estate,
G2b - Company Formation Agent,
G2b Construtora E Incorporadora,
G2b Media.
G2B Pharma Inc's categories are Pharmaceutical Manufacturing
